Page last updated: 2024-10-27

gabapentin and Acute Myelogenous Leukemia

gabapentin has been researched along with Acute Myelogenous Leukemia in 1 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Other Studies

1 other study available for gabapentin and Acute Myelogenous Leukemia

ArticleYear
Gabapentin. CI 945, GOE 3450, Neurontin.
    Drugs in R&D, 1999, Volume: 2, Issue:6

    Topics: Acetates; Adult; Amines; Anticonvulsants; Area Under Curve; Biological Availability; Child; Child, P

1999